iRhythm Technologies reported strong first quarter 2025 financial results with revenue exceeding 20% growth year-over-year, driven by increased demand for Zio services and momentum in value-based care accounts. The company also expanded its global reach with the launch of Zio monitor in Japan.
Revenue reached $158.7 million, a 20.3% increase compared to Q1 2024.
Gross margin improved to 68.8%, up 250 basis points from Q1 2024.
Net loss decreased to $30.7 million from $45.7 million in Q1 2024.
Unrestricted cash, cash equivalents, and marketable securities stood at $520.6 million as of March 31, 2025.
iRhythm projects revenue for the full year 2025 between $690 million to $700 million and adjusted EBITDA margin ranging from approximately 7.5% to 8.5% of revenues.